Bandhan Healthcare Fund · Regular · Growth
NAV
₹10.9850
as of 15 Jul 2026
Expense Ratio
2.41%
AUM
₹287 Cr
Lumpsum returns (CAGR)
- 1Y
- —
- 3Y
- —
- 5Y
- —
- Since Inception
- +9.47%
SIP returns (XIRR)
- 1Y
- —
- 3Y
- —
- 5Y
- —
- Since Inception
- +34.58%
Not enough verified history to show honest backtest scenarios (this fund is under 3 years old).
Performance Comparison
Sectoral allocation
as of 30 Apr 2026- Pharmaceuticals & Biotechnology64.00%
- Healthcare Services29.00%
- Insurance2.00%
Each sector links to the mutual funds most exposed to it.
Thinking about Bandhan Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Bandhan Healthcare Fund - Direct Plan - IDCW
- 1Sun Pharmaceutical Industries Limited9.34%
- 2Apollo Hospitals Enterprise Limited8.67%
- 3Divi'S Laboratories Limited7.61%
- 4Max Healthcare Institute Limited6.92%
- 5Cipla Limited6.76%
- 6Dr. Reddy'S Laboratories Limited5.92%
- 7Jb Chemicals & Pharmaceuticals Limited4.57%
- 8Mankind Pharma Limited3.48%
- 9Ajanta Pharma Limited2.91%
- 10Aurobindo Pharma Limited2.87%
Investment Objective
Bandhan Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Bandhan Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Bandhan Mutual Fund. The fund has been operational for over 0 years. It manages assets worth ₹287 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE HEALTHCARE INDEX TRI. The current expense ratio is 2.41%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations